Biomet Orthopedics has announced the first clinical use of its Signature patient-specific glenoid instrumentation in the US, which is designed to improve placement for total and reverse shoulder arthroplasty.
The Signature glenoid system uses CT data and a proprietary algorithm to match each patient’s anatomy and facilitate proper positioning of the glenoid component that allows surgeons to make any necessary adjustments before the surgery.
It was introduced in Europe in February 2013, and is used in conjunction with Biomet’s Comprehensive shoulder system.
This combination allows to position the glenoid component optimally and to implant the component with ease and speed.
Minnesota orthopedic surgeon Dr. John Sperling stated that Signature is a major advance in shoulder arthroplasty.
"In addition to providing a time-efficient and user-friendly solution to consistently place the glenoid component, Signature™ provides the surgeon the ability to seamlessly choose between anatomic and reverse shoulder arthroplasty," Dr Sperling added.
The Signature glenoid system complements Biomet’s access instrumentation for its Comprehensive shoulder platform, which features patent-pending, four-step cannulated glenoid instrumentation.
The Signature glenoid guide is reportedly the only device of its type that features a patent-pending dual trajectory, allowing surgeons to elect a reverse or total shoulder procedure intraoperatively.
Biomet also recently introduced Signature instrumentation for acetabular positioning in total hip replacement.